![Progression-Free Survival Is a Surrogate for Survival in Advanced Colorectal Cancer | Journal of Clinical Oncology Progression-Free Survival Is a Surrogate for Survival in Advanced Colorectal Cancer | Journal of Clinical Oncology](https://ascopubs.org/cms/10.1200/JCO.2007.11.8836/asset/images/zlj0330765900002.jpeg)
Progression-Free Survival Is a Surrogate for Survival in Advanced Colorectal Cancer | Journal of Clinical Oncology
![Definition of progression free survival and overall survival for the... | Download Scientific Diagram Definition of progression free survival and overall survival for the... | Download Scientific Diagram](https://www.researchgate.net/publication/265644752/figure/fig1/AS:269802786783234@1441337405030/Definition-of-progression-free-survival-and-overall-survival-for-the-Gold-standard-and.png)
Definition of progression free survival and overall survival for the... | Download Scientific Diagram
![Modified TPEx as First-line Treatment for Recurrent and/or Metastatic Head and Neck Cancer | Anticancer Research Modified TPEx as First-line Treatment for Recurrent and/or Metastatic Head and Neck Cancer | Anticancer Research](https://ar.iiarjournals.org/content/anticanres/41/4/2045/F1.large.jpg)
Modified TPEx as First-line Treatment for Recurrent and/or Metastatic Head and Neck Cancer | Anticancer Research
![Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review | British Journal of Cancer Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-020-0805-y/MediaObjects/41416_2020_805_Fig1_HTML.png)
Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review | British Journal of Cancer
![Overall survival (OS) and progression-free survival (PFS) according to... | Download Scientific Diagram Overall survival (OS) and progression-free survival (PFS) according to... | Download Scientific Diagram](https://www.researchgate.net/publication/365764852/figure/fig2/AS:11431281114465703@1674505116555/Overall-survival-OS-and-progression-free-survival-PFS-according-to-EOT-TGR-groups-in.png)
Overall survival (OS) and progression-free survival (PFS) according to... | Download Scientific Diagram
![Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41375-020-01042-y/MediaObjects/41375_2020_1042_Fig1_HTML.png)
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia
![Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41375-020-01042-y/MediaObjects/41375_2020_1042_Fig2_HTML.png)
Progression-free survival at 24 months and subsequent survival of patients with extranodal NK/T-cell lymphoma: a China Lymphoma Collaborative Group (CLCG) study | Leukemia
![Progression free survival (PFS) and overall survival (OS) by NLR. A)... | Download Scientific Diagram Progression free survival (PFS) and overall survival (OS) by NLR. A)... | Download Scientific Diagram](https://www.researchgate.net/publication/355902744/figure/fig3/AS:1086291840114704@1636003565564/Progression-free-survival-PFS-and-overall-survival-OS-by-NLR-A-Median-PFS-was-56.png)
Progression free survival (PFS) and overall survival (OS) by NLR. A)... | Download Scientific Diagram
![Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology](https://www.jcancer.org/ms/getimage.php?name=jcav10p3717g002.jpg)
Relationship between Progression-free Survival and Overall Survival in Randomized Clinical Trials of Targeted and Biologic Agents in Oncology
![Progression-free survival (PFS) and overall survival (OS) outcomes by... | Download Scientific Diagram Progression-free survival (PFS) and overall survival (OS) outcomes by... | Download Scientific Diagram](https://www.researchgate.net/publication/371972138/figure/fig4/AS:11431281172033895@1688427353295/Progression-free-survival-PFS-and-overall-survival-OS-outcomes-by-race-A-PFS.png)
Progression-free survival (PFS) and overall survival (OS) outcomes by... | Download Scientific Diagram
![Progression-free survival (PFS) and Overall survival (OS) for all 115 patients with follicular lymphoma according to the prognostic scoring system incorporating the 3 independent risk factors for both PFS and OS. Progression-free survival (PFS) and Overall survival (OS) for all 115 patients with follicular lymphoma according to the prognostic scoring system incorporating the 3 independent risk factors for both PFS and OS.](https://s3-eu-west-1.amazonaws.com/ppreviews-plos-725668748/525896/preview.jpg)
Progression-free survival (PFS) and Overall survival (OS) for all 115 patients with follicular lymphoma according to the prognostic scoring system incorporating the 3 independent risk factors for both PFS and OS.
![Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials - London - 2017 - Cancer - Wiley Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials - London - 2017 - Cancer - Wiley](https://acsjournals.onlinelibrary.wiley.com/cms/asset/7ec0391a-b577-4b44-aac8-535a76de8de5/cncr30934-fig-0001-m.jpg)
Historical time to disease progression and progression‐free survival in patients with recurrent/refractory neuroblastoma treated in the modern era on Children's Oncology Group early‐phase trials - London - 2017 - Cancer - Wiley
![Exploring the relationship between Overall Survival (OS), Progression Free Survival (PFS) and Objective Response Rate (ORR) in patients with advanced melanoma - ScienceDirect Exploring the relationship between Overall Survival (OS), Progression Free Survival (PFS) and Objective Response Rate (ORR) in patients with advanced melanoma - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2468294220301076-gr1.jpg)
Exploring the relationship between Overall Survival (OS), Progression Free Survival (PFS) and Objective Response Rate (ORR) in patients with advanced melanoma - ScienceDirect
![Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? - Abstract - Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? - Abstract -](https://europepmc.org/articles/PMC4367593/bin/tlcr-01-01-026-f2.jpg)
Statistical considerations and endpoints for clinical lung cancer studies: Can progression free survival (PFS) substitute overall survival (OS) as a valid endpoint in clinical trials for advanced non-small-cell lung cancer? - Abstract -
![Survival analysis and treatment. A. Progression Free Survival (PFS) and... | Download Scientific Diagram Survival analysis and treatment. A. Progression Free Survival (PFS) and... | Download Scientific Diagram](https://www.researchgate.net/publication/321881328/figure/fig2/AS:572930209267712@1513608614494/Survival-analysis-and-treatment-A-Progression-Free-Survival-PFS-and-B-Overall.png)
Survival analysis and treatment. A. Progression Free Survival (PFS) and... | Download Scientific Diagram
![Cancers | Free Full-Text | Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma Cancers | Free Full-Text | Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma](https://www.mdpi.com/cancers/cancers-13-00090/article_deploy/html/images/cancers-13-00090-g001.png)
Cancers | Free Full-Text | Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma
![Shows the progression-free survival (PFS) and overall survival (OS) by... | Download Scientific Diagram Shows the progression-free survival (PFS) and overall survival (OS) by... | Download Scientific Diagram](https://www.researchgate.net/publication/363493498/figure/fig1/AS:11431281127686255@1679111338499/Shows-the-progression-free-survival-PFS-and-overall-survival-OS-by-treatment.png)
Shows the progression-free survival (PFS) and overall survival (OS) by... | Download Scientific Diagram
![Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of](https://ascopubs.org/cms/10.1200/JCO.2014.56.5887/asset/images/zlj9991047350001.jpeg)
Individual Patient Data Analysis of Progression-Free Survival Versus Overall Survival As a First-Line End Point for Metastatic Colorectal Cancer in Modern Randomized Trials: Findings From the Analysis and Research in Cancers of
![Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy | British Journal of Cancer Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: a meta-analysis of randomised trials of first-line chemotherapy | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fbjc.2016.83/MediaObjects/41416_2016_Article_BFbjc201683_Fig2_HTML.jpg)